The immune system responds to tuberculosis (TB) infection by the formation of granulomas. However, subsequent immune-mediated destruction of lung tissue is a cause of significant morbidity and contributes to disease transmission. Lactoferrin, an iron-binding glycoprotein, has demonstrated immunomodulatory properties which decrease tissue destruction and promote T H 1 immune responses, both of which are essential for controlling TB infection. The cord factor trehalose 6,6'-dimycolate (TDM) model of granuloma formation mimics many aspects of TB infection, with similar histopathology accompanied by proinflammatory cytokine production. C57BL/6 mice were intravenously injected with TDM. A subset of mice was given 1 mg bovine lactoferrin 24 hours post-TDM challenge. Lung tissue was analyzed for histological response and production of proinflammatory mediators. C57BL/6 mice demonstrated granuloma formation that correlated with increased production of IL-1β, IL-6, TNF-α, IL-12p40, IFN-γ, and IL-10 protein. Mice treated with lactoferrin post-challenge had significantly fewer and smaller granulomas compared to those given TDM alone. Proinflammatory and T H 1 cytokines essential to the control of mycobacterial infections, such as TNF-α and IFN-γ, were not significantly different in mice treated with lactoferrin. Furthermore, the anti-inflammatory cytokines IL-10 and TGF-β were increased. A potential mechanism for decreased tissue damage seen in the lactoferrin treated mice is proposed. Because of its influence to modulate immune responses, lactoferrin may be a useful adjunct in the treatment of granulomatous inflammation occurring during mycobacterial infection.